June 1, 2022Comprehensive transcriptomic analysis of immune checkpoint markers in a pan-cancer cohort: Implications for response and resistance Read more »
July 1, 2022FDA-cleared elio™ tissue complete assay provides rapid, accurate, and actionable insights to guide targeted cancer therapies with a path to reimbursemen Read more »
April 1, 2022Prognostic value of post-surgery liquid biopsy cell-free circulating tumor DNA in stage III colon cancer patients - PLCRC-PROVENC3 study Read more »
April 1, 2022Comprehensive liquid biopsy profiling enabled by PGDx elio plasmaTM complete to facilitate precision oncology through decentralized access to testing Read more »
